Working here

[anonymous]

Over 80% of the reps nationwide will not bonus anything this QTR.

that’s what happens when you don’t produce Mary.

if you want a handout, go to the Salvation Army.

 

[anonymous]

that’s what happens when you don’t produce Mary.

if you want a handout, go to the Salvation Army.

Well, John. It seems you either don’t know how to read or just have terrible memory or both... there have been multiple situations historically where we do not always get paid when we produce. So save your fruitless knowledge

 

[anonymous]

That’s what happens when your company doesn’t produce a new product in an appropriate time frame, John.

I want a handout. I REALLLLY want a handout. In the form of ONE (JUST ONE) of the products that we were sold on as part of the “incredible pipeline” Supernus touts.

that’s what happens when you don’t produce Mary.

if you want a handout, go to the Salvation Army.

 

[anonymous]

That’s what happens when your company doesn’t produce a new product in an appropriate time frame, John.

I want a handout. I REALLLLY want a handout. In the form of ONE (JUST ONE) of the products that we were sold on as part of the “incredible pipeline” Supernus touts.

Well Sally you are going to have to keep waiting because 812 is going to be a dud.

 

[anonymous]

Well Sally you are going to have to keep waiting because 812 is going to be a dud.

812, if approved will be the new Oxtellar XR.

 

[anonymous]

812, if approved will be the new Oxtellar XR.

Please, please God no.

please.

 

[anonymous]

That’s what happens when your company doesn’t produce a new product in an appropriate time frame, John.

I want a handout. I REALLLLY want a handout. In the form of ONE (JUST ONE) of the products that we were sold on as part of the “incredible pipeline” Supernus touts.

Karen, you were already given a handout in the form of a sales position with Supernus.

Let’s not forget you were pushing cell phone plans prior to this opportunity.

I know you think mixing Rumchata drinks at Bunco makes you an analytical chemist, however in the real world of Pharmaceutical Development, there are delays and products that fail.

Given the number of companies that have hired for migraine positions recently, one could surmise that you are either happy sitting here complaining or couldn’t get anyone to hire you.

either way, winners get out and get it done. Losers sit around and bitch.

 

[anonymous]

Karen, you were already given a handout in the form of a sales position with Supernus.

Let’s not forget you were pushing cell phone plans prior to this opportunity.

I know you think mixing Rumchata drinks at Bunco makes you an analytical chemist, however in the real world of Pharmaceutical Development, there are delays and products that fail.

Given the number of companies that have hired for migraine positions recently, one could surmise that you are either happy sitting here complaining or couldn’t get anyone to hire you.

either way, winners get out and get it done. Losers sit around and bitch.

 

[anonymous]

Karen, you were already given a handout in the form of a sales position with Supernus.

Let’s not forget you were pushing cell phone plans prior to this opportunity.

I know you think mixing Rumchata drinks at Bunco makes you an analytical chemist, however in the real world of Pharmaceutical Development, there are delays and products that fail.

Given the number of companies that have hired for migraine positions recently, one could surmise that you are either happy sitting here complaining or couldn’t get anyone to hire you.

either way, winners get out and get it done. Losers sit around and bitch.

“There are delays and products that fail”.
Thank you for pointing this out. Supernus is a perfect example of this.

 

[anonymous]

Supn down 10% week over week

 

[anonymous]

“There are delays and products that fail”.
Thank you for pointing this out. Supernus is a perfect example of this.

“Nearly 14 percent of all drugs in clinical trials eventually win approval from the FDA according to a 2018 study from the MIT Sloan School of Management.“

I’ve been critical too of moves made on the commercial side and how the field is being treated, but you can’t make claims that R&D is subpar when we’ve had 2 products FDA approved, 2 indication adds, 1 submitted/accepted with 3 positive ph3 trials, and only 1 failed ph3.

If you are going to complain, at least make them valid complaints. You take away our credibility and make us all look bad when you say stuff like that.

 

[anonymous]

“Nearly 14 percent of all drugs in clinical trials eventually win approval from the FDA according to a 2018 study from the MIT Sloan School of Management.“

I’ve been critical too of moves made on the commercial side and how the field is being treated, but you can’t make claims that R&D is subpar when we’ve had 2 products FDA approved, 2 indication adds, 1 submitted/accepted with 3 positive ph3 trials, and only 1 failed ph3.

If you are going to complain, at least make them valid complaints. You take away our credibility and make us all look bad when you say stuff like that.

Don’t rain facts on Karen’s bitch fest!

what is she going to do with the rest of her day?

 

[anonymous]

“Nearly 14 percent of all drugs in clinical trials eventually win approval from the FDA according to a 2018 study from the MIT Sloan School of Management.“

I’ve been critical too of moves made on the commercial side and how the field is being treated, but you can’t make claims that R&D is subpar when we’ve had 2 products FDA approved, 2 indication adds, 1 submitted/accepted with 3 positive ph3 trials, and only 1 failed ph3.

If you are going to complain, at least make them valid complaints. You take away our credibility and make us all look bad when you say stuff like that.

We sat on our money wayyyy too long. The failure of supernus to reload the field with a new product is what has resulted in the abysmal stock price.

No too mention the intentional delays in 810 and 812. For fuc&ks sake we had fast track designation in 2014 by the FDA. It is now 2020!!!

 

[anonymous]

“Nearly 14 percent of all drugs in clinical trials eventually win approval from the FDA according to a 2018 study from the MIT Sloan School of Management.“

I’ve been critical too of moves made on the commercial side and how the field is being treated, but you can’t make claims that R&D is subpar when we’ve had 2 products FDA approved, 2 indication adds, 1 submitted/accepted with 3 positive ph3 trials, and only 1 failed ph3.

If you are going to complain, at least make them valid complaints. You take away our credibility and make us all look bad when you say stuff like that.

R&D should have been gutted after they dropped the ball with migraine in 2016 and 810 in 2019. They had nothing else going on. You mention 2 indication adds?? So was there alot of time and devotion collecting data from Trileptal and Topamax to get that migraine and monotherapy indication. Just shut your mouth. R&D is by far the companies weakest link. This is the division that has kneecaped the field.

 

[anonymous]

We sat on our money wayyyy too long. The failure of supernus to reload the field with a new product is what has resulted in the abysmal stock price.

No too mention the intentional delays in 810 and 812. For fuc&ks sake we had fast track designation in 2014 by the FDA. It is now 2020!!!

It’s safe to say we sat on money because there was nothing viable to buy.

Intentional delays? You’re telling me that you think someone with a brain consciously decided to delay 812 and put us in this limbo, sorry transformational, period...on purpose? Fast track was for 810 based on the fact it could be the first approved treatment for IA. The study didn’t show positive results, that happens.

 

[anonymous]

R&D should have been gutted after they dropped the ball with migraine in 2016 and 810 in 2019. They had nothing else going on. You mention 2 indication adds?? So was there alot of time and devotion collecting data from Trileptal and Topamax to get that migraine and monotherapy indication. Just shut your mouth. R&D is by far the companies weakest link. This is the division that has kneecaped the field.

Migraine 2016 - J&Js adult migraine indication rights expired before the adolescent indication. The FDA made the decision to not add the adult migraine indication to Trokendi XR until the adolescent indication expired to avoid off label promotion to adolescents.

810 - the molecule didn’t work for IA. Not sure how R&D could change that fact.

2 Indications - yes an indication add without trials is no easy feat. Enough historical data has to be collected, organized, and presented to leave the FDA with enough confidence to not require trials.

 

[anonymous]

R&D should have been gutted after they dropped the ball with migraine in 2016 and 810 in 2019. They had nothing else going on. You mention 2 indication adds?? So was there alot of time and devotion collecting data from Trileptal and Topamax to get that migraine and monotherapy indication. Just shut your mouth. R&D is by far the companies weakest link. This is the division that has kneecaped the field.

Hey man, it kinda seems like you’re going through a tough time. Understandable considering the current state of affairs with our country, Covid, and our company. In all seriousness, if you want we can set up ghost email accounts to chat on anonymously or something. It just feels like maybe you need someone to talk to that isn’t a toxic message board? Lemme know.

 

[anonymous]

Hey man, it kinda seems like you’re going through a tough time. Understandable considering the current state of affairs with our country, Covid, and our company. In all seriousness, if you want we can set up ghost email accounts to chat on anonymously or something. It just feels like maybe you need someone to talk to that isn’t a toxic message board? Lemme know.

Hey man it looks to me like you need a social life. You posted 3 times in thirty minutes. Get a grip.

 

[anonymous]

Hey man, it kinda seems like you’re going through a tough time. Understandable considering the current state of affairs with our country, Covid, and our company. In all seriousness, if you want we can set up ghost email accounts to chat on anonymously or something. It just feels like maybe you need someone to talk to that isn’t a toxic message board? Lemme know.

call 1800-TIME FOR NEW MANAGEMENT

 

[anonymous]

Hey man, it kinda seems like you’re going through a tough time. Understandable considering the current state of affairs with our country, Covid, and our company. In all seriousness, if you want we can set up ghost email accounts to chat on anonymously or something. It just feels like maybe you need someone to talk to that isn’t a toxic message board? Lemme know.

Thank god we have someone like Joe Biden as our next president. He will fix all this shit in the world!